Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 108

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Neuroinflammation: A Modifiable Pathway Linking Obesity, Alzheimer's disease, and Depression

Ly, Maria, Yu, Gary Z., Mian, Ali, Cramer, Austin, Meysami, Somayeh, Merrill, David A., Samara, Amjad, Eisenstein, Sarah A., Hershey, Tamara, Babulal, Ganesh M., Lenze, Eric J., Morris, John C., Benzinger, Tammie L.S., Raji, Cyrus A. · 2023 · The American Journal of Geriatric Psychiatry

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jagp.2023.06.001

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Research works printed but not linked: 111

  1. Gotlib, 2008, Handbook of depression
  2. Gutiérrez-Rojas, 2020, Prevalence and correlates of major depressive disorder: a systematic review, Braz J Psychiatry, 42, 657, 10.1590/1516-4446-2020-0650 · DOI · Paper page
  3. Laborde-Lahoz, 2015, Subsyndromal depression among older adults in the USA: prevalence, comorbidity, and risk for new-onset psychiatric disorders in late life, Int J Geriatr Psychiatry, 30, 677, 10.1002/gps.4204 · DOI
  4. Mohebbi, 2019, Prevalence of depressive symptoms and its associated factors among healthy community-dwelling older adults living in Australia and the United States, Int J Geriatr Psychiatry, 34, 1208, 10.1002/gps.5119 · DOI
  5. Barnes, 2012, Midlife vs late-life depressive symptoms and risk of dementia: differential effects for Alzheimer disease and vascular dementia, Arch Gen Psychiatry, 69, 493, 10.1001/archgenpsychiatry.2011.1481 · DOI · Paper page
  6. Butters, 2008, Pathways linking late-life depression to persistent cognitive impairment and dementia, Dialogues Clin Neurosci, 10, 345, 10.31887/DCNS.2008.10.3/mabutters · DOI · Paper page
  7. Babulal, 2016, Mood changes in cognitively normal older adults are linked to alzheimer disease biomarker levels, Am J Geriatr Psychiatry, 24, 1095, 10.1016/j.jagp.2016.04.004 · DOI
  8. Jantaratnotai, 2017, The interface of depression and obesity, Obes Res Clin Pract, 11, 1, 10.1016/j.orcp.2016.07.003 · DOI · Paper page
  9. Li, 2004, Obesity and depressive symptoms in Chinese elderly, Int J Geriatr Psychiatry, 19, 68, 10.1002/gps.1040 · DOI · Paper page
  10. Liu, 2020, Depressive symptoms and metabolic syndrome components among older Chinese adults, Diabetol Metab Syndr, 12, 18, 10.1186/s13098-020-00526-2 · DOI
  11. Sun, 2020, Late-life obesity is a protective factor for prodromal Alzheimer's disease: a longitudinal study, Aging (Albany NY), 12, 2005, 10.18632/aging.102738 · DOI
  12. Amabebe, 2020, Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism, Br J Nutr, 123, 1127, 10.1017/S0007114520000380 · DOI · Paper page
  13. Chen, 2018, Gut microbiome in obesity, metabolic syndrome, and diabetes, Curr Diab Rep, 18, 129, 10.1007/s11892-018-1104-3 · DOI
  14. Kacířová, 2020, Inflammation: major denominator of obesity, Type 2 diabetes and Alzheimer's disease-like pathology?, Clin Sci (Lond), 134, 547, 10.1042/CS20191313 · DOI
  15. You, 2013, Effects of exercise training on chronic inflammation in obesity: current evidence and potential mechanisms, Sports Med, 43, 243, 10.1007/s40279-013-0023-3 · DOI · Paper page
  16. Monteiro, 2006, Adipocyte size and liability to cell death, Obes Surg, 16, 804, 10.1381/096089206777346600 · DOI
  17. Artemniak-Wojtowicz, 2020, Obesity and chronic inflammation crosslinking, Cent Eur J Immunol, 45, 461, 10.5114/ceji.2020.103418 · DOI
  18. Xu, 2003, Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance, J Clin Invest, 112, 1821, 10.1172/JCI200319451 · DOI · Paper page
  19. Esser, 2013, Obesity phenotype is related to NLRP3 inflammasome activity and immunological profile of visceral adipose tissue, Diabetologia, 56, 2487, 10.1007/s00125-013-3023-9 · DOI · Paper page
  20. Rodríguez-Hernández, 2013, Obesity and inflammation: epidemiology, risk factors, and markers of inflammation, Int J Endocrinol, 2013, 10.1155/2013/678159 · DOI · Paper page
  21. Manabe, 2011, Chronic inflammation links cardiovascular, metabolic and renal diseases, Circ J, 75, 2739, 10.1253/circj.CJ-11-1184 · DOI · Paper page
  22. Wiebe, 2019, Associations of chronic inflammation, insulin resistance, and severe obesity with mortality, myocardial infarction, cancer, and chronic pulmonary disease, JAMA Netw Open, 2, 10.1001/jamanetworkopen.2019.10456 · DOI
  23. Amin, 2019, How the association between obesity and inflammation may lead to insulin resistance and cancer, Diabetes Metab Syndr, 13, 1213, 10.1016/j.dsx.2019.01.041 · DOI
  24. Pantoja-Meléndez, 2017, Low-grade inflammation and its relation to obesity and chronic degenerative diseases, Revista Médica Hospital Gen México, 80, 101, 10.1016/j.hgmx.2016.06.011 · DOI · Paper page
  25. Margină, 2020, Chronic inflammation in the context of everyday life: dietary changes as mitigating factors, Int J Environ Res Public Health, 17, 1, 10.3390/ijerph17114135 · DOI
  26. Ruiz, 2018, Neuroprogression: the hidden mechanism of depression, Neuropsychiatr Dis Treat, 14, 2837, 10.2147/NDT.S177973 · DOI
  27. Bruehl, 2009, Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus, Brain Res, 1280, 186, 10.1016/j.brainres.2009.05.032 · DOI · Paper page
  28. Benomar, 2019, Molecular mechanisms underlying obesity-induced hypothalamic inflammation and insulin resistance: pivotal role of resistin/TLR4 Pathways, Front Endocrinol (Lausanne), 10, 140, 10.3389/fendo.2019.00140 · DOI
  29. Chen, 2022, High-fat diet-induced obesity alters dendritic cell homeostasis by enhancing mitochondrial fatty acid oxidation, J Immunol, 209, 69, 10.4049/jimmunol.2100567 · DOI
  30. Malesza, 2021, High-fat, western-style diet, systemic inflammation, and gut microbiota: a narrative review, Cells, 10, 1, 10.3390/cells10113164 · DOI · Paper page
  31. Thaler, 2012, Obesity is associated with hypothalamic injury in rodents and humans, J Clin Invest, 122, 153, 10.1172/JCI59660 · DOI · Paper page
  32. Yoon, 2019, Transcriptomic analysis of high fat diet fed mouse brain cortex, Front Genet, 10, 83, 10.3389/fgene.2019.00083 · DOI
  33. Wang, 2019, AMPK signaling regulates the age-related decline of hippocampal neurogenesis, Aging Dis, 10, 1058, 10.14336/AD.2019.0102 · DOI
  34. Stranahan, 2008, Diet-induced insulin resistance impairs hippocampal synaptic plasticity and cognition in middle-aged rats, Hippocampus, 18, 1085, 10.1002/hipo.20470 · DOI · Paper page
  35. Takechi, 2017, Blood-brain barrier dysfunction precedes cognitive decline and neurodegeneration in diabetic insulin resistant mouse model: an implication for causal link, Front Aging Neurosci, 9, 399, 10.3389/fnagi.2017.00399 · DOI · Paper page
  36. Takechi, 2013, Aging-related changes in blood-brain barrier integrity and the effect of dietary fat, Neurodegener Dis, 12, 125, 10.1159/000343211 · DOI
  37. Kanoski, 2010, The effects of a high-energy diet on hippocampal function and blood-brain barrier integrity in the rat, J Alzheimers Dis, 21, 207, 10.3233/JAD-2010-091414 · DOI · Paper page
  38. Klockars, 2019, Hypothalamic integration of the endocrine signaling related to food intake, Curr Top Behav Neurosci, 43, 239, 10.1007/7854_2018_54 · DOI
  39. Cai, 2012, Inflammatory cause of metabolic syndrome via brain stress and NF-κB, Aging (Albany NY), 4, 98, 10.18632/aging.100431 · DOI · Paper page
  40. Miyamoto, 2013, Microglia and synapse interactions: fine tuning neural circuits and candidate molecules, Front Cell Neurosci, 7, 70, 10.3389/fncel.2013.00070 · DOI
  41. Maes, 2011, A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness, Prog Neuropsychopharmacol Biol Psychiatry, 35, 676, 10.1016/j.pnpbp.2010.05.004 · DOI · Paper page
  42. Kawasaki, 2012, Obesity-induced endoplasmic reticulum stress causes chronic inflammation in adipose tissue, Sci Rep, 2, 799, 10.1038/srep00799 · DOI · Paper page
  43. Reddy, 2018, Mutant APP and amyloid beta-induced defective autophagy, mitophagy, mitochondrial structural and functional changes and synaptic damage in hippocampal neurons from Alzheimer's disease, Hum Mol Genet, 27, 2502, 10.1093/hmg/ddy154 · DOI · Paper page
  44. Morrison, 2010, High fat diet increases hippocampal oxidative stress and cognitive impairment in aged mice: implications for decreased Nrf2 signaling, J Neurochem, 114, 1581, 10.1111/j.1471-4159.2010.06865.x · DOI · Paper page
  45. Riemer, 2013, Axonal transport and mitochondrial dysfunction in Alzheimer's disease, Neurodegener Dis, 12, 111, 10.1159/000342020 · DOI
  46. Serrano, 2004, Reactive oxygen species and synaptic plasticity in the aging hippocampus, Ageing Res Rev, 3, 431, 10.1016/j.arr.2004.05.002 · DOI · Paper page
  47. Fernández-Sánchez, 2011, Inflammation, oxidative stress, and obesity, Int J Mol Sci, 12, 3117, 10.3390/ijms12053117 · DOI · Paper page
  48. Bondia-Pons, 2012, Oxidative stress and inflammation interactions in human obesity, J Physiol Biochem, 68, 701, 10.1007/s13105-012-0154-2 · DOI · Paper page
  49. Singhal, 2017, Microglia: an interface between the loss of neuroplasticity and depression, Front Cell Neurosci, 11, 270, 10.3389/fncel.2017.00270 · DOI · Paper page
  50. Chylikova, 2018, M1/M2 macrophage polarization in human obese adipose tissue, Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 162, 79, 10.5507/bp.2018.015 · DOI
  51. Zhang, 2018, Switching of the microglial activation phenotype is a possible treatment for depression disorder, Front Cell Neurosci, 12, 306, 10.3389/fncel.2018.00306 · DOI · Paper page
  52. Kan, 2013, A systematic review and meta-analysis of the association between depression and insulin resistance, Diabetes Care, 36, 480, 10.2337/dc12-1442 · DOI · Paper page
  53. Jope, 2017, Stressed and inflamed, can GSK3 be blamed?, Trends Biochem Sci, 42, 180, 10.1016/j.tibs.2016.10.009 · DOI
  54. Lyra, 2019, Insulin resistance as a shared pathogenic mechanism between depression and type 2 diabetes, Front Psychiatry, 10, 57, 10.3389/fpsyt.2019.00057 · DOI · Paper page
  55. Leonard, 2020, Inflammation, insulin resistance and neuroprogression in depression, Acta Neuropsychiatr, 32, 1, 10.1017/neu.2019.17 · DOI
  56. Miller, 2014, Obesity and neuroinflammation: a pathway to cognitive impairment, Brain Behav Immun, 42, 10, 10.1016/j.bbi.2014.04.001 · DOI · Paper page
  57. 2016, Eirini CSaPDAaANM: obesity, inflammation and cognition, Curr Opin Behav Sci, 9, 169, 10.1016/j.cobeha.2016.05.004 · DOI
  58. Gray, 2013, Frailty and incident dementia, J Gerontol A Biol Sci Med Sci, 68, 1083, 10.1093/gerona/glt013 · DOI · Paper page
  59. Sutin, 2019, Perceived weight discrimination and risk of incident dementia, Int J Obes (Lond), 43, 1130, 10.1038/s41366-018-0211-1 · DOI
  60. Sutin, 2020, Perceived weight discrimination and performance in five domains of cognitive function, J Psychosom Res, 131, 10.1016/j.jpsychores.2019.109793 · DOI
  61. Wang, 2004, Weight loss, nutritional status and physical activity in patients with Alzheimer's disease. A controlled study, J Neurol, 251, 314, 10.1007/s00415-004-0316-4 · DOI
  62. Sergi, 2013, Weight loss and Alzheimer's disease: temporal and aetiologic connections, Proc Nutr Soc, 72, 160, 10.1017/S0029665112002753 · DOI
  63. Cova, 2016, Weight loss predicts progression of mild cognitive impairment to Alzheimer's Disease, PLoS One, 11, 10.1371/journal.pone.0151710 · DOI
  64. McGuire, 2016, Leptin dysfunction and Alzheimer's disease: evidence from cellular, animal, and human studies, Cell Mol Neurobiol, 36, 203, 10.1007/s10571-015-0282-7 · DOI
  65. Saha, 2016, Appetite and weight loss symptoms in late-life depression predict dementia outcomes, Am J Geriatr Psychiatry, 24, 870, 10.1016/j.jagp.2016.05.004 · DOI
  66. Huffman, 2002, Evaluating and treating unintentional weight loss in the elderly, Am Fam Phys, 65, 640
  67. Torres-Perez, 2016, Apolipoprotein E4 association with metabolic syndrome depends on body fatness, Atherosclerosis, 245, 35, 10.1016/j.atherosclerosis.2015.11.029 · DOI
  68. Tejedor, 2014, The apolipoprotein E polymorphism rs7412 associates with body fatness independently of plasma lipids in middle aged men, PLoS One, 9, 10.1371/journal.pone.0108605 · DOI
  69. Elosua, 2003, Obesity modulates the association among APOE genotype, insulin, and glucose in men, Obes Res, 11, 1502, 10.1038/oby.2003.201 · DOI
  70. Zade, 2013, Apolipoprotein epsilon 4 allele modifies waist-to-hip ratio effects on cognition and brain structure, J Stroke Cerebrovasc Dis, 22, 119, 10.1016/j.jstrokecerebrovasdis.2011.06.020 · DOI
  71. Stunkard, 2003, Depression and obesity, Biol Psychiatry, 54, 330, 10.1016/S0006-3223(03)00608-5 · DOI · Paper page
  72. Roberts, 2003, Prospective association between obesity and depression: evidence from the Alameda County Study, Int J Obes Relat Metab Disord, 27, 514, 10.1038/sj.ijo.0802204 · DOI · Paper page
  73. Roberts, 2000, Are the obese at greater risk for depression?, Am J Epidemiol, 152, 163, 10.1093/aje/152.2.163 · DOI · Paper page
  74. de Groot, 2010, Depression among adults with diabetes: prevalence, impact, and treatment options, Diabetes Spectr, 23, 15, 10.2337/diaspect.23.1.15 · DOI
  75. Repousi, 2018, Depression and metabolic syndrome in the older population: a review of evidence, J Affect Disord, 237, 56, 10.1016/j.jad.2018.04.102 · DOI
  76. de la Torre-Luque, 2019, Inflammatory and metabolic disturbances are associated with more severe trajectories of late-life depression, Psychoneuroendocrinology, 110, 10.1016/j.psyneuen.2019.104443 · DOI
  77. Kokkeler, 2022, Frailty measures in immuno-metabolic subtypes of late-life depression; a two-year prospective study, Arch Gerontol Geriatr, 99, 10.1016/j.archger.2021.104603 · DOI
  78. Felger, 2018, Imaging the role of inflammation in mood and anxiety-related disorders, Curr Neuropharmacol, 16, 533, 10.2174/1570159X15666171123201142 · DOI · Paper page
  79. Babulal, 2022, The complex relationship between depression and progression to incident cognitive impairment across race and ethnicity, Alzheimers Dement, 12, 1
  80. Deurenberg, 2002, Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship, Obes Rev, 3, 141, 10.1046/j.1467-789X.2002.00065.x · DOI · Paper page
  81. Zenebe, 2021, Prevalence and determinants of depression among old age: a systematic review and meta-analysis, Ann Gen Psychiatry, 20, 55, 10.1186/s12991-021-00375-x · DOI · Paper page
  82. Vyas, 2020, Association of race and ethnicity with late-life depression severity, symptom burden, and care, JAMA Netw Open, 3, 10.1001/jamanetworkopen.2020.1606 · DOI
  83. You, 2004, Effects of hypocaloric diet and exercise training on inflammation and adipocyte lipolysis in obese postmenopausal women, J Clin Endocrinol Metab, 89, 1739, 10.1210/jc.2003-031310 · DOI · Paper page
  84. Pontiroli, 2009, In morbid obesity, metabolic abnormalities and adhesion molecules correlate with visceral fat, not with subcutaneous fat: effect of weight loss through surgery, Obes Surg, 19, 745, 10.1007/s11695-008-9626-4 · DOI
  85. Chiappetta, 2018, The Impact of obesity and metabolic surgery on chronic inflammation, Obes Surg, 28, 3028, 10.1007/s11695-018-3320-y · DOI
  86. Emery, 2007, Gastric bypass surgery is associated with reduced inflammation and less depression: a preliminary investigation, Obes Surg, 17, 759, 10.1007/s11695-007-9140-0 · DOI
  87. Middleton, 2010, Physical activity over the life course and its association with cognitive performance and impairment in old age, J Am Geriatr Soc, 58, 1322, 10.1111/j.1532-5415.2010.02903.x · DOI · Paper page
  88. Hopps, 2011, Effects of exercise on inflammation markers in type 2 diabetic subjects, Acta Diabetol, 48, 183, 10.1007/s00592-011-0278-9 · DOI
  89. Tapia-Rojas, 2016, Voluntary running attenuates memory loss, decreases neuropathological changes and induces neurogenesis in a mouse model of Alzheimer's disease, Brain Pathol, 26, 62, 10.1111/bpa.12255 · DOI · Paper page
  90. Reycraft, 2020, Exercise intensity and recovery on circulating brain-derived neurotrophic factor, Med Sci Sports Exerc, 52, 1210, 10.1249/MSS.0000000000002242 · DOI
  91. Mariani, 2022, Modulation of microglial activation by antidepressants, J Psychopharmacol, 36, 131, 10.1177/02698811211069110 · DOI
  92. Haussmann, 2021, Lithium: a therapeutic option in Alzheimer's disease and its prodromal stages?, Neurosci Lett, 760, 10.1016/j.neulet.2021.136044 · DOI
  93. Matsunaga, 2015, Lithium as a treatment for Alzheimer's disease: a systematic review and meta-analysis, J Alzheimers Dis, 48, 403, 10.3233/JAD-150437 · DOI · Paper page
  94. Bagheri, 2020, The effects of statins on microglial cells to protect against neurodegenerative disorders: a mechanistic review, Biofactors, 46, 309, 10.1002/biof.1597 · DOI
  95. Saeedi, 2017, The beneficial effects of HMG-CoA reductase inhibitors in the processes of neurodegeneration, Metab Brain Dis, 32, 949, 10.1007/s11011-017-0021-5 · DOI
  96. Majidazar, 2022, Pharmacotherapy of Alzheimer's disease: an overview of systematic reviews, Eur J Clin Pharmacol, 78, 1567, 10.1007/s00228-022-03363-6 · DOI
  97. Zhang, 2018, NSAID exposure and risk of Alzheimer's disease: an updated meta-analysis from cohort studies, Front Aging Neurosci, 10, 83, 10.3389/fnagi.2018.00083 · DOI · Paper page
  98. Aisen, 2003, Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial, JAMA, 289, 2819, 10.1001/jama.289.21.2819 · DOI · Paper page
  99. Attwells, 2020, Translocator protein distribution volume predicts reduction of symptoms during open-label trial of celecoxib in major depressive disorder, Biol Psychiatry, 88, 649, 10.1016/j.biopsych.2020.03.007 · DOI
  100. Meyer, 2020, Neuroinflammation in psychiatric disorders: PET imaging and promising new targets, Lancet Psychiatry, 7, 1064, 10.1016/S2215-0366(20)30255-8 · DOI · Paper page
  101. Walter, 2004, Cannabinoids and neuroinflammation, Br J Pharmacol, 141, 775, 10.1038/sj.bjp.0705667 · DOI · Paper page
  102. Savonenko, 2015, Cannabinoid CB2 receptors in a mouse model of Aβ amyloidosis: immunohistochemical analysis and suitability as a PET biomarker of neuroinflammation, PLoS One, 10, 10.1371/journal.pone.0129618 · DOI
  103. Kenou, 2022, Cyclooxygenases as potential pet imaging biomarkers to explore neuroinflammation in dementia, J Nucl Med, 63, 53S, 10.2967/jnumed.121.263199 · DOI
  104. Janssen, 2019, Development of brain PET imaging agents: strategies for imaging neuroinflammation in Alzheimer's disease, Prog Mol Biol Transl Sci, 165, 371, 10.1016/bs.pmbts.2019.04.005 · DOI
  105. Bambach, 2022, Arterial spin labeling applications in pediatric and adult neurologic disorders, J Magn Reson Imaging, 55, 698, 10.1002/jmri.27438 · doi:10.1002/jmri.27438
  106. Winkeler, 2010, Radioisotopic imaging of neuroinflammation, J Nucl Med, 51, 1, 10.2967/jnumed.109.065680 · DOI
  107. Tolomeo, 2018, Chemical exchange saturation transfer MRI shows low cerebral 2-deoxy-D-glucose uptake in a model of Alzheimer's disease, Sci Rep, 8, 9576, 10.1038/s41598-018-27839-7 · DOI
  108. Wang, 2019, Quantification of white matter cellularity and damage in preclinical and early symptomatic Alzheimer's disease, Neuroimage Clin, 22, 10.1016/j.nicl.2019.101767 · DOI · Paper page
  109. Cross, 2017, A new imaging modality to non-invasively assess multiple sclerosis pathology, J Neuroimmunol, 304, 81, 10.1016/j.jneuroim.2016.10.002 · DOI
  110. Samara, 2019, Neuroinflammation and white matter alterations in obesity assessed by diffusion basis spectrum imaging, Front Hum Neurosci, 13, 464, 10.3389/fnhum.2019.00464 · DOI
  111. Ly, 2021, Obesity and white matter neuroinflammation related edema in Alzheimer's disease dementia biomarker negative cognitively normal individuals, J Alzheimers Dis, 79, 1801, 10.3233/JAD-201242 · DOI

Cited by

See all 108

Metadata

Authors
Ly, M., Yu, G. Z., Mian, A., Cramer, A., Meysami, S., Merrill, D. A., Samara, A., Eisenstein, S. A., Hershey, T., Babulal, G. M., Lenze, E. J., Morris, J. C., Benzinger, T. L. S., & Raji, C. A.
Venue
The American Journal of Geriatric Psychiatry
Publisher
Elsevier BV
Published
2023-10
Volume
31
Issue
10
Pages
853-866
ISSN
1064-7481
Cited by
108
References
29
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
National Institutes of Health (1RF1AG072637-01, P01AG003991, P01AG026276, P30 AG066444, R01AG056466, R01AG067428, R01AG068183, R01AG074302, U19 AG024904, U19 AG032438)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neuroinflammation: A Modifiable Pathway Linking Obesity, Alzheimer's disease, and Depression. https://app.cochat.ai/papers/10.1016/j.jagp.2023.06.001
The paper
Ly, M., Yu, G. Z., Mian, A., Cramer, A., Meysami, S., Merrill, D. A., Samara, A., Eisenstein, S. A., Hershey, T., Babulal, G. M., Lenze, E. J., Morris, J. C., Benzinger, T. L. S., & Raji, C. A. (2023). Neuroinflammation: A Modifiable Pathway Linking Obesity, Alzheimer's disease, and Depression. The American Journal of Geriatric Psychiatry. https://doi.org/10.1016/j.jagp.2023.06.001

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.